CARE Ratings Q3 FY25 earnings call: Revenue & Margins
Q3 FY25 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹96Cr
- +21.5% YoY
- −17.9% QoQ
- Net profit
- ₹28Cr
- +16.7% YoY
- −40.4% QoQ
- Margin
- 32%
- +2 pp YoY
- −15 pp QoQ
Guidance rank: #20 of 27 in Capital Markets
See the sector's top 10 — free with your mobile number.
Based on CARE Ratings Ltd's Q3 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Standalone Revenue from Operations for Q3FY25: Rs. 78.59 Crs, up 18% YoY (Page 2, 12). Consolidated Q3FY25 Figures (Page 13):.
From CARE Ratings Ltd's Q3 FY25 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Standalone Revenue from Operations for Q3FY25: Rs. 78.59 Crs, up 18% YoY (Page 2, 12)
- Standalone EBITDA for Q3FY25: Rs. 30.30 Crs, up 12% YoY (Page 2, 12)
- Standalone PAT for Q3FY25: Rs. 30.30 Crs, up 33% YoY (Page 2, 12)
- Consolidated Revenue from Operations for Q3FY25: Rs. 96.38 Crs, up 22% YoY (Page 2, 13)
- Consolidated EBITDA for Q3FY25: Rs. 30.43 Crs, up 30% YoY (Page 2, 13)
- Consolidated PAT for Q3FY25: Rs. 28.37 Crs, up 19% YoY (Page 2, 13)
2 more points from CARE Ratings Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
Consolidated Q3FY25 Figures (Page 13):
Locked: what CARE Ratings Ltd said on margins
Also locked on this page: capex, fundraising, order book
Free account, 30 seconds. No card needed.
Capital Expenditure Plans
See what CARE Ratings Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Capital Markets
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
There is information on fundraising activity in the economy, noting a 5% year-on-year rise in corporate…
Locked: what CARE Ratings Ltd said on fundraising
Also locked on this page: margins, capex, order book
Free account, 30 seconds. No card needed.
Order Book & Pipeline
See what CARE Ratings Ltd said on order book & pipeline — free account, 30 seconds.
CARE Ratings Ltd — Quarterly revenue & net profit
CARE Ratings Ltd Q3 FY25 results — key figures
| ₹ Cr | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 96 | 79 | +21.5% | 117 | -17.9% |
| Operating profit (EBITDA) | 30 | 23 | +30.4% | 56 | -46.4% |
| Operating margin | 32% | 30% | +2 pp | 47% | -15 pp |
| Profit before tax | 39 | 34 | +14.7% | 64 | -39.1% |
| Net profit (PAT) | 28 | 24 | +16.7% | 47 | -40.4% |
| EPS (₹) | 9.29 | 7.88 | +17.9% | 15.41 | -39.7% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹164 Cr, net profit ₹72 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What CARE Ratings's management said in earlier quarters
Others in Capital Markets this season
- ICRA (Q3 FY25)
Q3 FY2025 Revenue: ₹120.9 crore, up 5.5% YoY from ₹114.6 crore in Q3 FY2024 (Page 6). Key concall takeaways from ICRA Ltd's Q3 FY25 earnings call — and how it…
- IIFL Capital (Q3 FY25)
Revenue for Q3FY25: ₹6,464 million, up 11% YoY (Page 20) . Key concall takeaways from IIFL Capital Services Ltd's Q3 FY25 earnings call — and how it ranks…
- 360 ONE (Q3 FY25)
Q3 FY25 Total Revenues: INR 678 Crs, up 45.4% YoY (Page 2) . Key concall takeaways from 360 ONE WAM Ltd's Q3 FY25 earnings call — and how it ranks against…
- Geojit Financial Services (Q3 FY25)
Market Capitalization:** ₹3,227 crore (as on 31-Dec-2024) . Key concall takeaways from Geojit Financial Services Ltd's Q3 FY25 earnings call — and how it ranks…
Potential multibaggers · Q2 FY27
Potential multibaggers in Capital Markets
on management's own guidance
- Motilal Oswal Financial ServicesGood growth2
- BSEGood growth1
- Anand Rathi WealthGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
CARE Ratings Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were CARE Ratings Ltd Q3 FY25 results?
Standalone Revenue from Operations for Q3FY25: Rs. 78.59 Crs, up 18% YoY (Page 2, 12). Consolidated Q3FY25 Figures (Page 13):.
What is CARE Ratings Ltd share price analysis?
CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 28.3 with a market cap of ₹5,026 Cr. Investors should review the full earnings analysis for detailed insights.
Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.